328 related articles for article (PubMed ID: 19664838)
1. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Miele L; Vallone S; Cefalo C; La Torre G; Di Stasi C; Vecchio FM; D'Agostino M; Gabrieli ML; Vero V; Biolato M; Pompili M; Gasbarrini G; Rapaccini G; Amerio P; De Simone C; Grieco A
J Hepatol; 2009 Oct; 51(4):778-86. PubMed ID: 19664838
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Gisondi P; Targher G; Zoppini G; Girolomoni G
J Hepatol; 2009 Oct; 51(4):758-64. PubMed ID: 19560226
[TBL] [Abstract][Full Text] [Related]
3. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
Madanagobalane S; Anandan S
Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
[TBL] [Abstract][Full Text] [Related]
4. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome.
Uchil D; Pipalia D; Chawla M; Patel R; Maniar S; Narayani ; Juneja A
J Assoc Physicians India; 2009 Mar; 57():201-4. PubMed ID: 19588647
[TBL] [Abstract][Full Text] [Related]
5. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
[TBL] [Abstract][Full Text] [Related]
7. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients.
Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S
Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
[TBL] [Abstract][Full Text] [Related]
10. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
Shieh K; Gilchrist JM; Promrat K
Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.
Harrison SA; Oliver D; Arnold HL; Gogia S; Neuschwander-Tetri BA
Gut; 2008 Oct; 57(10):1441-7. PubMed ID: 18390575
[TBL] [Abstract][Full Text] [Related]
13. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
[TBL] [Abstract][Full Text] [Related]
14. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
[TBL] [Abstract][Full Text] [Related]
15. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
Lu H; Zeng L; Liang B; Shu X; Xie D
Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
[TBL] [Abstract][Full Text] [Related]
18. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
Graham RC; Burke A; Stettler N
J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Prashanth M; Ganesh HK; Vima MV; John M; Bandgar T; Joshi SR; Shah SR; Rathi PM; Joshi AS; Thakkar H; Menon PS; Shah NS
J Assoc Physicians India; 2009 Mar; 57():205-10. PubMed ID: 19588648
[TBL] [Abstract][Full Text] [Related]
20. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis.
Manco M; Bedogni G; Marcellini M; Devito R; Ciampalini P; Sartorelli MR; Comparcola D; Piemonte F; Nobili V
Gut; 2008 Sep; 57(9):1283-7. PubMed ID: 18218674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
